Panel Discussion: Bridging the Gap from Innovation to Access by Aligning Standardization, Policy & Reimbursement for Liquid Biopsy

1:00 pm - Wednesday 4th February 2026

  • Uncovering how inconsistent definitions, metrics, and data standards are hindering payer confidence and policy support for liquid biopsy
  • Exploring the role of pre-competitive collaboration in driving standardization to unlock broader reimbursement and clinical adoption
  • Identifying immediate policy actions and evidence needs to align stakeholders and accelerate access to serial testing and early detection

Speakers:

Medical Director
Kaiser Permanente
Director
Faster Cures - Milken Institute
Exec Dir
Amgen Inc.
Executive Director
BLOODPAC